Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
McKesson
Baxter
Johnson and Johnson
Federal Trade Commission

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 8,962,590

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,962,590
Title:Prostate cancer vaccine
Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
Inventor(s): McNeel; Douglas G. (Madison, WI), Olson; Brian M. (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation (Madison, WI)
Application Number:13/968,854
Patent Claims:see list of patent claims

Details for Patent 8,962,590

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Wisconsin Alumni Research Foundation (Madison, WI) 2027-08-31 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Wisconsin Alumni Research Foundation (Madison, WI) 2027-08-31 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Wisconsin Alumni Research Foundation (Madison, WI) 2027-08-31 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,962,590

Country Patent Number Publication Date
United States of America 10111940 Oct 30, 2018
United States of America 2008063654 Mar 13, 2008
United States of America 2012020912 Jan 26, 2012
United States of America 2014105853 Apr 17, 2014
United States of America 2015306197 Oct 29, 2015
United States of America 2017014498 Jan 19, 2017
United States of America 2019038732 Feb 07, 2019
>Country >Patent Number >Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Deloitte
Accenture
Chinese Patent Office
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.